Children's Tumor Foundation

Children's Tumor
Foundation Research
Published in
New England Journal
of Medicine

Learn more

Our vision is to end NF

The Children's Tumor Foundation's mission is to drive research, expand knowledge, and advance care for the NF community.

Research for a cure

Since its formation, the Children’s Tumor Foundation has been crucial to the development of solid scientific data about the genetic disorder neurofibromatosis (NF). Thanks to the generosity of our donors and supporters, we are breaking through barriers and forging the pathway that will lead to a cure.

Learn More

Get to know our NF Heroes

Meet Them

Fundraising Programs

NF WALK
NF ENDURANCE
CLASSROOMS FOR A CURE
DO-IT-YOURSELF

Upcoming Events

Latest News

From Process to Progress: Children’s Tumor Foundation Annual Report

Jun 22, 2017, Posted in Latest News

We’re proud to announce that our latest annual report – titled From Process to Progress – is now available to read online. Outlining the Foundation’s activities over the past year, from research to awareness to patient support, the annual report highlights a vibrant NF community that is making great progress in the fight to end NF. Additionally, the financial pages offer transparency on how funds are spent, earning the Foundation a four-star rating from Charity Navigator once again. And of course, none of this is possible without the support of all of you – the thousands of donors who give to ensure that NF research and programs continue.

More >

2017 NF Conference Program Book Now Available

Jun 22, 2017

The 2017 NF Conference program book is now available.

More >

Seeking grant applications for MPNST research at Boston Children’s Hospital

Jun 22, 2017, Posted in Collaborations, Outside Opportunities, Science

The NF Research Initiative (NFRI) at Boston Children’s Hospital has two open requests for applications:

More >

Research & Development VP Salvo La Rosa interviewed in research publication

Jun 21, 2017, Posted in CTF in the News, Published, Science

Children's Tumor Foundation Research & Development VP Salvo La Rosa was interviewed by Outsourcing-Pharma.com on how disease-focused foundations and contract research organizations (CROs) are working together to bridge the gap between drug discovery and development, a topic that will be addressed at BIO2017, the global event for biotechnology, this week.

More >